The role of radiotherapy in lung cancer: Where is the evidence?>

Radiotherapy and Oncology

Volumn 83, Issue 2, 2007, Pages 203-213

  Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Accelerated radiotherapy; Chemoradiotherapy; Hyperfractionated radiotherapy; Hypofractionated radiotherapy; IMRT; Lung cancer; NSCLC; Palliative radiotherapy; Postoperative radiotherapy; Preoperative radiotherapy; Prophylactic cranial irradiation; Radical radiotherapy; Radiotherapy; SCLC; Stereotactic radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOMYCIN; VINBLASTINE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; DOSE RESPONSE; EVIDENCE BASED MEDICINE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; PALLIATIVE THERAPY; PANCOAST TUMOR; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; PALLIATIVE CARE; RADIOTHERAPY DOSAGE;

EID: 34248681578     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.04.004     Document Type: Review

References (86)

1. Albain K.S., Swann R.S., Rusch V.R., et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309). Proc Am Soc Clin Oncol 23 (2005) 624s
2. Andre F., Grunenwald D., Pignon J.P., Dujon A., Pujol J.L., Brichon P.Y., et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 18 (2000) 2981-2989
3. Aupérin A., Le Pechoux C., Pignon J.P., et al. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol 17 (2006) 473-483
4. Aupérin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341 (1999) 476-484
5. Ball D., Bishop J., Smith J., et al. A randomized phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol 52 (1999) 129-136
6. Baumann M., Herrmann T., Koch R., et al. Continuous hyperfractionated accelerated radiotherapy - weekend less (CHARTWEL) versus conventionally fractionated (CF) radiotherapy in non-small-cell lung cancer (NSCLC): first results of a phase III randomised multicentre trial (ARO 971). Eur J Cancer 3 (2005) 323
7. Belderbos J., Heemsbergen W., Hoogeman M., Pengel K., Rossi M., and Lebesque J. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
8. Bezjak A., Dixon P., Brundage M., et al. Randomized study of single versus fractionated radiotherapy (RT) in the palliation of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 719-728
9. Blanke C., Ansari R., Mantravadi R., et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol. J Clin Oncol 13 (1995) 1425-1429
10. Blommaert F.A., van Dijk-Knijnenburg H.C., Dijt F.J., den Engelse L., Baan R.A., Berends F., et al. Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells. Biochemistry 34 (1995) 8474-8480
11. Bonner J.A., Sloan J.A., Shanahan T.G., et al. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol 17 (1999) 2681-2691
12. Brodin O., Nou E., Mercke C., et al. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. Eur J Cancer 32A (1996) 1893-1900
13. Burdett S., and Stewart L. Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 47 (2005) 81-83
14. Cakir S., and Egehan I. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer. Lung Cancer 43 (2004) 309-316
15. Clamon G., Herndon J., Cooper R., Chang A.Y., Rosenman J., and Green M.R. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 4-11
16. Cullen M.H., Billingham L.J., Woodrofee C.M., et al. Mitomycin, ifosfamide and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 17 (1999) 3188-3194
17. Curran W.J., Scott C.B., Langer C.J., et al. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III nsclc: RTOG 9410. Proc Am Soc Clin Oncol 22 (2003) 621s
18. Dautzenberg B., Arriagada R., Chammard A.B., et al. A randomised trial evaluating post-op RT in NSCLC after complete surgical resection. Cancer 86 (1999) 265-273
19. Debevec M., Bitenc M., Vidmar S., et al. Post-operative radiotherapy for radically resected N2 non-small cell lung cancer: randomised clinical study 1988-92. Lung Cancer 14 (1996) 99-107
20. Delaney G., Barton M., Jacob S., and Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol 4 (2003) 120-128
21. Dillman R.O., Herndon J., Seagren S.L., Eaton W.L., and Green M.R. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996) 1210-1215
22. Dillman R.O., Seagren S.L., Herndon J., et al. A randomized trial of induction chemotherapy plus high-dose radiotherapy vs. radiotherapy alone in stage III non-small cell lung cancer. N Engl J Med 323 (1990) 940-945
23. Eichhorn H.J., Eule H., Lessel A., and Menne W. Results of a controlled clinical trial for evaluation of intensive preoperative irradiation in operable bronchial cancer. Archiv Geschwulst 45 (1975) 376-384
24. Fairlamb D., Milroy R., Gower N., Parmar M., Peake M., Rudd R., et al. A randomised comparison of radical radiotherapy with or without chemotherapy for patients with non-small lung cancer: results from the Big Lung Trial. Radiother Oncol 75 (2005) 134-140
25. Falk S.J., Girling D.J., White R.J., et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. BMJ 325 (2002) 465-468
26. Feng Q.F., Wang M., Wang L.J., et al. A study of postoperative radiotherapy in patients with non-small cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 47 (2000) 925-929
27. Fournel P., Robinet G., Thomas P., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. J Clin Oncol 23 (2005) 5910-5917
28. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
29. Gervais R., Ducolone A., Lechevalier T., et al. Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatin (P)]: final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT. Proc Am Soc Clin Oncol 23 (2005) 625s
30. Hotta K., Matsuo K., Ueoka H., Kiura K., Tabata M., and Tanimoto M. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 22 (2004) 3852-3859
31. Huber R.M., Flentje M., Schmidt M., et al. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: Study CTRT99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol 27 (2006) 4397-4404
32. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer 1991;63:265-70.
33. Jassem J. Combined chemotherapy and radiation in locally advanced nonsmall-cell lung cancer. Lancet Oncol 2 (2001) 335-342
34. Jassem J. Postoperative chemotherapy in non-small cell lung cancer: still more questions than answers. Future Oncol 2 (2006) 569-571
35. Jeremic B., Shibamoto Y., Acimovic L., and Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14 (1996) 1065-1070
36. Jeremic B., Shibamoto Y., Acimovic L., and Djuric L. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol 13 (1995) 452-458
37. Johnson D.H., Einhorn L.H., Bartolucci A., et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 113 (1990) 33-38
38. Keller S.M., Sudeshna A., Wagner H., et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer. N Engl J Med 343 (2000) 1217-1222
39. Kramer G.W.P.M., Wanders S.L., Noordijk E.M., et al. Results of the Dutch National Study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol 23 (2005) 2962-2970
40. Lafitte J.J., Ribet M.E., Prévost B.M., Gosselin B.H., Copin M.-C., and Brichet A.H. Post-irradiation for T2 N0 M0 non-small cell carcinoma: a prospective randomized study. Ann Thor Surg 62 (1996) 830-834
41. Lavrenkov K., Partridge M., Cook G., and Brada M. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. Radiother Oncol 77 (2005) 1-4
42. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung cancer: first analysis of a randomised trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
43. Le Chevalier T., Arriagada R., Tarayre M., et al. Significant effect of adjuvant chemotherapy on survival in locally advanced nonsmall-cell lung carcinoma [letter]. J Natl Cancer Inst 84 (1992) 58
44. Lester J.F., Macbeth F.R., Toy E., and Coles B. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 4 (2006) CD002143
45. Lievens Y., Kesteloot K., and Van den Bogaert W. CHART in lung cancer: economic evaluation and incentives for implementation. Radiother Oncol 75 (2005) 171-178
46. Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986;315:1377-81.
47. Macbeth F.R., Abratt R.P., Cho K.H., Stephens R.J., Jeremic B., and for the International Atomic Energy Agency. Lung cancer management in limited resource settings: guidelines for appropriate good care. Radiother Oncol 82 (2007) 123-131
48. Macbeth F.R., Bolger J.J., and Hopwood P. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol 8 (1996) 167-175
49. Mattson K., Holsti L.P., Holsti P., et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 24 (1988) 477-482
50. Medical Research Council Lung Cancer Working Party. A Medical Research Council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992;65:934-41.
51. Morton R.F., Jett J.R., McGinnis W.L., et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer: a randomized, phase III trial. Ann Intern Med 115 (1991) 681-686
52. 18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81 (2006) 209-225
53. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995;311:899-909.
54. Perez C.A., Pajak T.F., Rubin P., et al. Long-term observations of the pattern of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 59 (1987) 1874-1881
55. Perez C.A., Stanley K., Rubin P., et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 45 (1980) 2744-2753
56. Pignon J.P., Arriagada R., Ihde D.C., et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 327 (1992) 1618-1624
57. Pijls-Johannesma M.C.G., De Ruysscher D., Lambin P., Rutten I., and Vansteenkiste J.F. Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev 4 (2004) CD004700
58. PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005;2:CD002142.
59. PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005;2:CD002142.
60. Rees G.J., Devrell C.E., Barley V.L., and Newman H.F. Palliative radiotherapy for lung cancer: two versus five fractions. Clin Oncol 9 (1997) 90-95
61. Reinfuss M., Gliński B., Kowalska T., et al. Radiotherapie du cancer bronchique non a petites cellules de stade III, inoperable, asymptomatique. Results definitifs d'un essai prospectif randomise (240 patients). Cancer Radiother 3 (1997) 475-479
62. Roswit R., Patno M.E., Rapp P., et al. The survival of patients with inoperable lung cancer: a large scale randomised study of radiation therapy versus placebo. Radiology 90 (1968) 688-697
63. Rowell N.P., and O'Rourke N.P. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2 (2004) CD002140
64. Rusch V.W., Giroux D.J., Kraut M.J., Crowley J., Hazuka M., Winton T., et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 25 (2007) 313-318
65. Rusch V.W., Parekh K.R., Leon L., Venkatraman E., Bains M.S., Downey R.J., et al. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg 119 (2000) 1147-1153 Review
66. Saunders M., Dische S., Barrett A., Harvey A., Gibson D., and Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet 350 (1997) 161-165
67. Sause W., Kolesar P., Taylor S., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117 (2000) 358-364
68. Sause W., Scott C., Taylor S., et al. RTOG 88-08, ECOG 4588, preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87 (1995) 198-205
69. Schaake-Koning C., van den Bogaert W., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326 (1992) 524-530
70. Senkus-Konefka E., Dziadziuszko R., Bednaruk-Młyński E., et al. A prospective, randomized study to compare the value of two fractionation schedules of palliative radiotherapy for inoperable non-small cell lung cancer. Br J Cancer 92 (2005) 1038-1045
71. Shields T.W. Pre-operative radiotherapy in the treatment of bronchial carcinoma. Cancer 30 (1972) 1388-1394
72. Simpson J.R., Francis M.E., Perez-Tamayo R., Marks R.D., and Rao D.V. Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 11 (1985) 751-758
73. Stephens R.J., Girling D.J., Bleehen N.M., Moghissi K., Yosef H.M., and Machin D. The role of post-operative radiotherapy in non-small cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Br J Cancer 74 (1996) 632-639
74. Sundstrøm S., Bremnes R., Aasebo U., Aamdal S., et al. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol 22 (2004) 801-810
75. Sundstrom S., Bremnes R., Brunsvig P., et al. Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study. Radiother Oncol 75 (2005) 141-148
76. Teo P., Tai T.H., Choy D., and Tsui K.H. A randomized study on palliative radiation therapy for inoperable non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 14 (1988) 867-871
77. Trodella L., Granone P., Valente S., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomised trial. Radiother Oncol 62 (2002) 11-19
78. Trovo M.G., Minatel E., Veronesi A., et al. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study. Cancer 65 (1990) 400-404
79. Trovo N.G., Minatel E., Fravelun G., et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 24 (1992) 11-15
80. Turrisi A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340 (1999) 265-271
81. Van Houtte P., Rocmans P., Smets P., et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 6 (1980) 983-986
82. Van Meerbeck J.P., Kramer G.W.P.M., Van Schil P.E.Y., et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. J Natl Cancer Inst 99 (2007) 442-450
83. Vokes E.E., Herndon II J.E., Kelley M.J., Watson D., Cicchetti M.G., and Green M.R. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25 (2007) 1698-1704
84. Warram J. Preoperative irradiation of cancer of the lung: final report of a therapeutic trial. A collaborative study. Cancer 36 (1975) 914-925
85. Wulf J., Baier K., Mueller G., and Flentje M.P. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83-87
86. Zatloukal P., Petruzelka L., Zemanova M., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46 (2004) 87-98